CMS’s new ACCESS Model is not just a chronic-care pilot. It signals a structural shift toward outcome-based, digitally managed reimbursement. For revenue cycle leaders, ACCESS previews how recurring payments, documentation standards, and data quality expectations will reshape chronic-care economics by 2030.

The proposed 2026 340B rebate model would replace upfront drug discounts with delayed reimbursement, shifting liquidity and compliance risk directly onto hospitals. For CFOs, this is not just a policy dispute but a fundamental change in cash flow, margin protection, and enterprise risk management—especially for safety-net providers.